ST3GAL4 Protein, Human, Recombinant (HA, His)

SKU TMPK-00944-100 μg Category Recombinant-Protein Brand: TargetMol

Price range: 1,117 CAD through 4,480 CAD

Size

100 μg 500 μg

Clear

Products Details

Product Description

– ST3GAL4 gene expression is altered in different cancer types, including cervical cancer. Several mRNA transcripts have been reported for this gene. ST3GAL4 encodes for β‑galactosidase α‑2,3‑sialyltransferase 4, involved in the biosynthesis of the tumour antigens sLe(x) and sulfo‑sLe(x).

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– TMPK-00944

Storage Temperature

– -20℃

Shipping

– Blue Ice

References

– Roa-de La Cruz L, et al. Expression analysis of ST3GAL4 transcripts in cervical cancer cells. Mol Med Rep. 2018 Jul;18(1):617-62doi: 10.3892/mmr.2018.8938. Epub 2018 Apr 27. PMID: 29749491.

Molecular Weight

Product type

– Recombinant-Protein

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.